Update on the combination of myo-inositol/d-chiro-inositol for the treatment of polycystic ovary syndrome

被引：4

作者：

Lete, Inaki ^{[1
,2
]}

Martinez, Ainara ^{[1
]}

Lasaga, Irene ^{[1
]}

Centurion, Eva ^{[1
]}

Vesga, Amaia ^{[1
]}

机构：

[1] Araba Univ Hosp, Obstet & Gynaecol Clin Management Unit, Vitoria, Spain

[2] Araba Univ Hosp, Obstet & Gynaecol Clin Management Unit, Txagorritxu Campus, Vitoria 01009, Spain

来源：

GYNECOLOGICAL ENDOCRINOLOGY | 2024年 / 40卷 / 01期

关键词：

Polycystic ovary syndrome; inositol; MYO/DCI ratio; HUMAN THECAL CELLS; GROWTH-FACTOR-I; FOLLICULAR-FLUID; OOCYTE QUALITY; THERAPEUTIC APPROACH; ANDROGEN PRODUCTION; GENE-PRODUCTS; IGF-II; MYOINOSITOL; WOMEN;

D O I：

10.1080/09513590.2023.2301554

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In this article, we present a narrative review on the use of inositol in the treatment of polycystic ovary syndrome (PCOS). Of the different inositols that exist, only myo-inositol (MYO) and D-chiro inositol (DCI) have been studied in the treatment of PCOS. The results of the studies show that there is insufficient or controversial evidence to recommend the use of DCI alone, while MYO alone shows positive results and, above all, the MYO/DCI combination is effective when used at a ratio of at least 40:1, but there is enough rationale to further study ratios such as 66:1 to 100:1 as other possible effective combinations.

引用

页数：5

共 50 条

[31] Determination of Myo-inositol and D-chiro-inositol in black rice bran by capillary electrophoresis with electrochemical detection
Kong, Lingyao
Wang, Yun
Cao, Yuhua
JOURNAL OF FOOD COMPOSITION AND ANALYSIS, 2008, 21 (06) : 501 - 504
[32] Myo-inositol, D-chiro-inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation
Malvasi, A.
Casciaro, F.
Minervini, M. M.
Kosmas, I.
Mynbaev, O. A.
Pacella, E.
Condesnitt, V. Monti
Creanza, A.
Di Renzo, G. C.
Tinelli, A.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (02) : 270 - 274
[33] Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors
Garzon, Simone
Lagana, Antonio Simone
Monastra, Giovanni
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2019, 15 (09) : 697 - 703
[34] The combined therapy myo-inositol plus d-chiro-inositol, rather than d-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial
Sandra Colazingari
Mariangela Treglia
Robert Najjar
Arturo Bevilacqua
Archives of Gynecology and Obstetrics, 2013, 288 : 1405 - 1411
[35] myo-Inositol, D-chiro-inositol, and D-pinitol synthesis, transport, and galactoside formation in soybean explants
Gomes, CI
Obendorf, RL
Horbowicz, M
CROP SCIENCE, 2005, 45 (04) : 1312 - 1319
[36] Does ovary need D-chiro-inositol?
Isabella R.
Raffone E.
Journal of Ovarian Research, 5 (1)
[37] Comparison between effects of myo-inositol and D-chiro-inositol on ovarian function and metabolic factors in women with PCOS
Pizzo, Alfonsa
Lagana, Antonio Simone
Barbaro, Luisa
GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (03) : 205 - 208
[38] Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus
Aisling Murphy
Amir Shamshirsaz
Daniela Markovic
Richard Ostlund
Brian Koos
Reproductive Sciences, 2016, 23 : 365 - 371
[39] Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus
Murphy, Aisling
Shamshirsaz, Amir
Markovic, Daniela
Ostlund, Richard
Koos, Brian
REPRODUCTIVE SCIENCES, 2016, 23 (03) : 365 - 371
[40] The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes
Pintaudi, Basilio
Di Vieste, Giacoma
Bonomo, Matteo
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2016, 2016

← 1 2 3 4 5 →